Changmei Medtech


Clinical study reveals new approach for the diagnosis of low back pain

Researchers have discovered a new, personalized approach for the diagnosis of low back pain based on patients’ biochemical profiles.
 
A clinical study conducted by researchers at The Feinstein Institute for Medical Research in collaboration with Norwell Health analyzed cytokines, specifically interleukin-6 (IL-6), to learn their influence on the behavior and pain levels of patients with lower back pain. Researchers also looked at the effect of BMI, symptom duration and patient age on serum levels.
Read more ...